Literature DB >> 17762627

Renal cell carcinoma: imaging and therapy.

Damien M Bolton1, Peter Wong, Nathan Lawrentschuk.   

Abstract

PURPOSE OF REVIEW: The increasing use of ultrasound and computerized tomography has led to over 50% of renal cell carcinomas being incidentally detected. With an increasing number of small and asymptomatic tumors being identified it is particularly important for an accurate diagnosis to be reached via available imaging modalities to permit selection of patients for surgical treatment. The identification of patients suitable for management via nephron-sparing surgery is a key issue. RECENT
FINDINGS: Advances in imaging have focused on the ability to distinguish malignant from nonmalignant tumors. Advanced assessments have aimed to identify the cancer subtype preoperatively in order to limit the requirement for surgery in carcinomas with low metastatic potential. Improved staging of renal tumors with magnetic resonance imaging and positron emission tomography has allowed more accurate preoperative assessment and planning of treatment for both organ-confined and extensive renal tumors. Radioimmunoscintigraphy and radioimmunotherapy also offer potential for therapeutic intervention at an antigen-directed level.
SUMMARY: More accurate matching of therapeutic options to newly diagnosed renal carcinomas is now possible with contemporary imaging techniques in order to limit morbidity of surgical treatment. The potential for urologists to progress to treatment of renal malignancies via advanced radiographic techniques is fast approaching.

Entities:  

Mesh:

Year:  2007        PMID: 17762627     DOI: 10.1097/MOU.0b013e3282e7d87b

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  6 in total

Review 1.  Imaging of advanced renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

Review 2.  An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions.

Authors:  Ravinder Kaur; Mamta Juneja; A K Mandal
Journal:  Med Biol Eng Comput       Date:  2019-11-21       Impact factor: 2.602

3.  Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma.

Authors:  David M Schuster; Jonathon A Nye; Peter T Nieh; John R Votaw; Raghuveer K Halkar; Muta M Issa; Weiping Yu; Julio Sepulveda; Wanzhen Zeng; Andrew Young; Mark M Goodman
Journal:  Mol Imaging Biol       Date:  2009-05-16       Impact factor: 3.488

4.  Renal cell carcinoma and arterial hypertension.

Authors:  Milan Stojanovic; Branislav Goldner; Dusan Ivkovic
Journal:  Clin Exp Nephrol       Date:  2009-01-29       Impact factor: 2.801

Review 5.  The use of dynamic nuclear polarization (13)C-pyruvate MRS in cancer.

Authors:  Henrik Gutte; Adam Espe Hansen; Helle Hjorth Johannesen; Andreas Ettrup Clemmensen; Jan Henrik Ardenkjær-Larsen; Carsten Haagen Nielsen; Andreas Kjær
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 6.  National nephrectomy registries: Reviewing the need for population-based data.

Authors:  John Pearson; Timothy Williamson; Joseph Ischia; Damien M Bolton; Mark Frydenberg; Nathan Lawrentschuk
Journal:  Korean J Urol       Date:  2015-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.